Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $97.50

Shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report) have earned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $97.50.

USPH has been the topic of several recent research reports. Citizens Jmp reiterated a “market outperform” rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Finally, Barrington Research dropped their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th.

View Our Latest Stock Analysis on USPH

U.S. Physical Therapy Stock Up 1.3%

U.S. Physical Therapy stock opened at $74.51 on Thursday. The stock has a market cap of $1.13 billion, a PE ratio of 149.02, a price-to-earnings-growth ratio of 2.03 and a beta of 1.15. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19. U.S. Physical Therapy has a one year low of $58.19 and a one year high of $93.50. The stock has a fifty day moving average of $66.20 and a 200 day moving average of $74.73.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.09). The firm had revenue of $198.29 million during the quarter, compared to analysts’ expectations of $200.94 million. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.48 earnings per share. As a group, sell-side analysts predict that U.S. Physical Therapy will post 2.99 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 22nd were issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 368.00%.

Insider Buying and Selling

In related news, Director Peter Francis Minan bought 492 shares of the stock in a transaction that occurred on Monday, June 8th. The shares were bought at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the transaction, the director owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. This trade represents a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.40% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. City Center Advisors LLC bought a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at approximately $283,000. Parallel Advisors LLC raised its stake in U.S. Physical Therapy by 75.2% during the 1st quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock worth $59,000 after acquiring an additional 337 shares during the period. Bank of America Corp DE lifted its holdings in U.S. Physical Therapy by 10.9% during the first quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock valued at $41,574,000 after purchasing an additional 54,656 shares in the last quarter. California State Teachers Retirement System lifted its holdings in U.S. Physical Therapy by 41.4% during the first quarter. California State Teachers Retirement System now owns 19,687 shares of the company’s stock valued at $1,476,000 after purchasing an additional 5,763 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in shares of U.S. Physical Therapy by 22.0% in the first quarter. Royal Bank of Canada now owns 133,777 shares of the company’s stock worth $10,029,000 after purchasing an additional 24,081 shares during the period.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

Featured Articles

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.